Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab

results from the DAHANCA 19 trial

Line Brøndum, Jan Alsner, Brita Singers Sørensen, Christian Maare, Jørgen Johansen, Hanne Primdahl, Jan Folkvard Evensen, Claus Andrup Kristensen, Lisbeth Juhler Andersen, Jens Overgaard, Jesper Grau Eriksen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

3 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind57
Udgave nummer9
Sider (fra-til)1159-1164
Antal sider6
ISSN0284-186X
DOI
StatusUdgivet - 2018

Fingerprint

Head and Neck Neoplasms
Exanthema
Single Nucleotide Polymorphism
Survival
Epidermal Growth Factor
Alleles
Radiation
erbB-1 Genes
zalutumumab
Therapeutics
Genes
Comorbidity
Odds Ratio

Citer dette

Brøndum, Line ; Alsner, Jan ; Sørensen, Brita Singers ; Maare, Christian ; Johansen, Jørgen ; Primdahl, Hanne ; Evensen, Jan Folkvard ; Kristensen, Claus Andrup ; Andersen, Lisbeth Juhler ; Overgaard, Jens ; Eriksen, Jesper Grau. / Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab : results from the DAHANCA 19 trial. I: Acta Oncologica. 2018 ; Bind 57, Nr. 9. s. 1159-1164.
@article{0f049e4e48ee49c984135fbf4a99df3c,
title = "Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial",
author = "Line Br{\o}ndum and Jan Alsner and S{\o}rensen, {Brita Singers} and Christian Maare and J{\o}rgen Johansen and Hanne Primdahl and Evensen, {Jan Folkvard} and Kristensen, {Claus Andrup} and Andersen, {Lisbeth Juhler} and Jens Overgaard and Eriksen, {Jesper Grau}",
year = "2018",
doi = "10.1080/0284186X.2018.1464664",
language = "English",
volume = "57",
pages = "1159--1164",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Taylor & Francis",
number = "9",

}

Brøndum, L, Alsner, J, Sørensen, BS, Maare, C, Johansen, J, Primdahl, H, Evensen, JF, Kristensen, CA, Andersen, LJ, Overgaard, J & Eriksen, JG 2018, 'Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial', Acta Oncologica, bind 57, nr. 9, s. 1159-1164. https://doi.org/10.1080/0284186X.2018.1464664

Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab : results from the DAHANCA 19 trial. / Brøndum, Line; Alsner, Jan; Sørensen, Brita Singers; Maare, Christian; Johansen, Jørgen; Primdahl, Hanne; Evensen, Jan Folkvard; Kristensen, Claus Andrup; Andersen, Lisbeth Juhler; Overgaard, Jens; Eriksen, Jesper Grau.

I: Acta Oncologica, Bind 57, Nr. 9, 2018, s. 1159-1164.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab

T2 - results from the DAHANCA 19 trial

AU - Brøndum, Line

AU - Alsner, Jan

AU - Sørensen, Brita Singers

AU - Maare, Christian

AU - Johansen, Jørgen

AU - Primdahl, Hanne

AU - Evensen, Jan Folkvard

AU - Kristensen, Claus Andrup

AU - Andersen, Lisbeth Juhler

AU - Overgaard, Jens

AU - Eriksen, Jesper Grau

PY - 2018

Y1 - 2018

U2 - 10.1080/0284186X.2018.1464664

DO - 10.1080/0284186X.2018.1464664

M3 - Journal article

VL - 57

SP - 1159

EP - 1164

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 9

ER -